Oncomatryx Announces FDA and AEMPS IND Clearance for OMTX705

After 15 years of pioneering R&D efforts in the tumor microenvironment, Oncomatryx announces that the FDA and the Spanish Drug Agency (AEMPS) have cleared its investigational new drug (IND) application

Related Keywords

Germany , United States , Spain , Pedro Esnaola , Kostenloser Wertpapierhandel , Spanish Drug Agency , Institute Of Cell Biology , Immunology Of The University Stuttgart Germany , Bizkaia Technology Park Bilbao , Cancer Associated Fibroblasts , Bizkaia Technology Park , Cell Biology , Oncomatryx , Nnounces , Temps , Clearance , Mtx705 , First , Glass , Humor , Microenvironment , Argeted , Treat , Dvanced , Olid , Rumors ,